Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
暂无分享,去创建一个
M. Krucoff | S. Windecker | J. Massaro | L. Mauri | R. Yeh | D. Cohen | P. Steg | D. Kereiakes | D. Cutlip | J. Hermiller | Wen-hua Hsieh | D. Cohen